These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18081947)

  • 21. Immunotherapy with GD2 specific monoclonal antibodies.
    Cheung NK; Medof ME; Munn D
    Prog Clin Biol Res; 1988; 271():619-32. PubMed ID: 3043454
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.
    Heiss P; Bernatz S; Bruchelt G; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3177-8. PubMed ID: 9329630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody.
    Wang CH; Huang YJ; Chang CW; Hsu WM; Peng CA
    Nanotechnology; 2009 Aug; 20(31):315101. PubMed ID: 19597244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
    Cheung NK; Miraldi FD
    Prog Clin Biol Res; 1988; 271():595-604. PubMed ID: 3406022
    [No Abstract]   [Full Text] [Related]  

  • 26. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
    Ricart AD; Tolcher AW
    Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy--nursing requirements--presentation of care in immunotherapy with monoclonal antibodies as a part of the treatment of metastasized neuroblastoma IV].
    Lehner C
    Kinderkrankenschwester; 1998 Nov; 17(11):476-80. PubMed ID: 9887744
    [No Abstract]   [Full Text] [Related]  

  • 28. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
    Amadori S; Stasi R
    Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of ovarian cancer.
    Kirby TO; Huh W; Alvarez R
    Expert Opin Biol Ther; 2002 Apr; 2(4):409-17. PubMed ID: 11955278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel antibodies as anticancer agents.
    Zafir-Lavie I; Michaeli Y; Reiter Y
    Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
    Cheung NK; Saarinen U; Neely J; Miraldi F; Strandjord S; Warkentin P; Coccia P
    Prog Clin Biol Res; 1985; 175():501-5. PubMed ID: 3991743
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic application of radiolabelled monoclonal antibody UJ13A in children with disseminated neuroblastoma--a phase 1 study.
    Kemshead JT; Goldman A; Jones D; Pritchard J; Malpas JS; Gordon I; Malone JF; Hurley GD; Breatnach F
    Prog Clin Biol Res; 1985; 175():533-44. PubMed ID: 4039447
    [No Abstract]   [Full Text] [Related]  

  • 33. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.
    Novak-Hofer I; Amstutz HP; Mäcke HR; Schwarzbach R; Zimmermann K; Morgenthaler JJ; Schubiger PA
    Cancer Res; 1995 Jan; 55(1):46-50. PubMed ID: 7805039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune therapies for neuroblastoma.
    Navid F; Armstrong M; Barfield RC
    Cancer Biol Ther; 2009 May; 8(10):874-82. PubMed ID: 19342881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases.
    Dadachova E; Casadevall A
    Curr Opin Investig Drugs; 2008 Feb; 9(2):184-8. PubMed ID: 18246521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy improves survival for patients with neuroblastoma.
    McBride D
    ONS Connect; 2009 Aug; 24(8):17. PubMed ID: 19715061
    [No Abstract]   [Full Text] [Related]  

  • 39. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts.
    Ostermann E; Garin-Chesa P; Heider KH; Kalat M; Lamche H; Puri C; Kerjaschki D; Rettig WJ; Adolf GR
    Clin Cancer Res; 2008 Jul; 14(14):4584-92. PubMed ID: 18628473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in monoclonal antibody-based therapies.
    Samaranayake H; Wirth T; Schenkwein D; Räty JK; Ylä-Herttuala S
    Ann Med; 2009; 41(5):322-31. PubMed ID: 19234897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.